Eli Lilly and Co logo

Eli Lilly and Co

LLY
Healthcare|Drug Manufacturers - General|USA
$927.06
-8.52 (-0.91%)
DCF (FCF)
$74.80
Tangible Book
$15.77
Graham Number
$92.73
Earnings Power
$55.36

About

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Stock Price

+17.5%(1Y)

Pipeline Summary

513 total trials
170
Phase 1
140
Phase 2
139
Phase 3
46
Phase 4
Completed: 384Terminated: 44Active: 20Unknown: 7APPROVED_FOR_MARKETING: 3Recruiting: 40Withdrawn: 7NOT_YET_RECRUITING: 5SUSPENDED: 1NO_LONGER_AVAILABLE: 1ENROLLING_BY_INVITATION: 1

Active Trials (60)

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421Neoplasms
Phase 3Active
Enrollment: 831 participants
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
NCT04469764Recurrent Endometrial Carcinoma
Phase 2Recruiting
Enrollment: 32 participants
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function
NCT06916078Liver Dysfunction
Phase 1Recruiting
Enrollment: 33 participants
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
NCT05617885Metastatic Prostate Cancer
Phase 1Active
Enrollment: 9 participants
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3Active
Enrollment: 17,300 participants

BioScore

7.4/10
Buy

Ownership

Recent Insider Trades

LILLY ENDOWMENT INCSELL
2026-01-07292,148 shares @ $1103.48
LILLY ENDOWMENT INCSELL
2026-01-051,390 shares @ $1085.01
LILLY ENDOWMENT INCSELL
2025-12-293,593 shares @ $1085.04
LILLY ENDOWMENT INCSELL
2025-12-242,629 shares @ $1085.17
LILLY ENDOWMENT INCSELL
2025-12-23240 shares @ $1085.04

Recent News

2026-04-02 17:26:08
2026-04-02 14:03:58
2026-04-02 11:30:59
2026-04-02 09:53:27
2026-04-01 18:52:06
Data last updated: Apr 7, 2026, 03:42 AM